Verbatim response from ChatGPT
Short answer: Yes — a BMI of 31 meets the FDA label for Wegovy (semaglutide) for chronic weight management in adults (the label is BMI ≥30, or BMI ≥27 with at least one weight‑related condition). That said, Wegovy is a prescription medicine and you must be evaluated by a clinician to confirm it’s safe and appropriate for you.
Who can prescribe it online
- Your own primary care provider via a telehealth visit — many PCPs will evaluate and prescribe GLP‑1 weight medicines if appropriate.
- An obesity‑medicine or endocrinology specialist offering telehealth. They often do more detailed metabolic workups.
- Commercial telehealth services that provide virtual weight‑loss care and can prescribe GLP‑1s when clinically appropriate. Examples:
- Calibrate — a program focused on GLP‑1–based, long‑term weight management with medical oversight and coaching.
- Hims & Hers — offers telemedicine visits and prescriptions for semaglutide/tirzepatide options; convenient for routine follow‑up.
- PlushCare — primary‑care telemedicine that can evaluate and prescribe weight‑loss medications when appropriate.
- Ro (Roman) / SteadyMD — primary‑care/weight‑management telehealth providers that connect you to clinicians who may prescribe GLP‑1s. (Availability varies by state and by individual medical history.)
What to expect in the evaluation
- Medical history and medication review (family history of medullary thyroid carcinoma or MEN2 is a contraindication).
- Pregnancy test if applicable (not to be used in pregnancy).
- Questions about past pancreatitis, gallbladder disease, severe GI disease, kidney disease, and current blood sugar medications (risk of hypoglycemia if used with insulin or sulfonylureas).
- Baseline labs may be ordered (A1c, kidney function, liver tests, lipids) and follow‑up visits arranged.
- If prescribed, Wegovy is a once‑weekly injectable started at a low dose and gradually titrated.
Cost and coverage
- Wegovy can be expensive without coverage. Insurance coverage varies; many insurers do not cover it for weight loss. Check your insurer and the manufacturer savings/assistance programs. Telehealth services often help with prior authorization and pharmacy options.
Alternatives
- Other GLP‑1 or dual agonist options exist (for example, tirzepatide brand Zepbound for weight management) and may be offered depending on your needs and what the clinician deems best.
If you’d like, I can:
- Help you find telehealth services that operate in your state, or
- Draft a short message you can send to your PCP to ask about Wegovy, or
- List questions to ask a telehealth clinician about safety, cost, and follow‑up. Which would you prefer?